Prosecution Insights
Last updated: July 17, 2026
Application No. 18/315,651

BIO-BASED HDPE FOR NON-WOVEN APPLICATION

Non-Final OA §103§112§DP
Filed
May 11, 2023
Priority
May 11, 2022 — provisional 63/340,779
Examiner
USELDING, JOHN E
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Braskem S.A.
OA Round
1 (Non-Final)
53%
Grant Probability
Moderate
1-2
OA Rounds
0m
Est. Remaining
71%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allowance Rate
684 granted / 1280 resolved
-11.6% vs TC avg
Strong +18% interview lift
Without
With
+17.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
61 currently pending
Career history
1343
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
67.0%
+27.0% vs TC avg
§102
4.8%
-35.2% vs TC avg
§112
3.6%
-36.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1280 resolved cases

Office Action

§103 §112 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of Group I, claims 1-13 in the reply filed on 4/24/2026 is acknowledged. The traversal is on the ground(s) that it is alleged that the Office has not met the burden of showing that the groups are patentably distinct. This is not found persuasive because the requirement for restriction of 2/25/2026 has demonstrated that the groups are patentably distinct. The requirement is still deemed proper and is therefore made FINAL. Claims 14-23 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected Group, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on 4/24/2026. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 3 and 6 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The limitation “base” in claim 3 is indefinite. The metes and bounds are unclear. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1, 2, 4, 5 and 7-13 is/are rejected under 35 U.S.C. 103 as being unpatentable over Graham et al. (WO 95/19391). Regarding claims 1-2 and 13: Graham et al. teach a composition comprising high density polyethylene (page 9, lines 24-25), 300 ppm of I-3114 (a primary antioxidant that is an isocyanurate), 710 ppm of a I-168 (a secondary antioxidant that is a phosphite) (Example 1), and 380 ppm of zinc stearate (neutralizer) (Example 1). Graham et al. teach using a diphosphate interchangeably with a phosphite (Page 15, liens 3-9; Claim 1). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use a diphosphite in place of the phosphite in Example 1 of Graham et al. Graham et al. teach using hydrotalcite (layered double hydroxide) interchangeably with zinc stearate (Claim 1). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use a hydrotalcite in place of the zinc stearate in Example 1 of Graham et al. The limitation “at least a portion of ethylene from HDPE is obtained from a renewable source of carbon” is a product by process limitation that specifies the source of the ethylene. The structures are so similar, a small amount of radioactive carbon-14 being the only difference, that the skilled artisan would expected them to have the same properties. A prima facie case of obviousness may be made when chemical compounds have very close structural similarities and similar utilities. "An obviousness rejection based on similarity in chemical structure and function entails the motivation of one skilled in the art to make a claimed compound, in the expectation that compounds similar in structure will have similar properties." In re Payne, 606 F.2d 303, 313, 203 USPQ 245, 254 (CCPA 1979). See In re Papesch, 315 F.2d 381, 137 USPQ 43 (CCPA 1963) (discussed in more detail below) and In re Dillon, 919 F.2d 688, 16 USPQ2d 1897 (Fed. Cir. 1991) (discussed below and in MPEP § 2144) for an extensive review of the case law pertaining to obviousness based on close structural similarity of chemical compounds. See also MPEP § 2144.08, paragraph II.A.4.(c). Regarding claims 4-5 and 7-8: Graham et al. teach the claimed primary antioxidant (Example 1), secondary antioxidant (page 15, lines 5-8), and hydrotalcite (claim 1), which comprises Mg and Al (page 16, lines 10-13). Regarding claims 9-12: Since the composition is the same as claimed, it will possess the claimed properties. The courts have stated that a chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. In re Spada, 911 F.2d 705, 15 USPQ2d 1655, (Fed. Cir. 1990). See also In re Best, 562 F.2d 1252, 195 USPQ 430, (CCPA 1977). "Where the claimed and prior art products are identical or substantially identical in structure or composition, or are produced by identical or substantially identical processes, a prima facie case of either anticipation or obviousness has been established." Further, if it is the applicant's position that this would not be the case, evidence would need to be provided to support the applicant's position. Claim(s) 3 and 6 is/are rejected under 35 U.S.C. 103 as being unpatentable over Graham et al. (WO 95/19391) as applied to claim 1 above further in view of Avakian et al. (EP 0781805 A1). Graham et al. teach adding a hindered amine stabilizer (claim 10). Graham et al. fail to teach the claimed compound. However, Avakian et al. teach that triisopropanol amine is a sterically hindered amine stabilizer known in the art, in an analogous composition (page 4, lines 5-7). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use triisopropanol amine as taught by Avakian et al. as the hindered amine stabilizer in Graham et al. to stabilize the composition. Claim(s) 1, 2, 4, 5 and 7-13 is/are rejected under 35 U.S.C. 103 as being unpatentable over Graham et al. (WO 95/19391) in view of Nakanishi et al. (2022/0135778). Regarding claims 1-2 and 13: Graham et al. teach a composition comprising high density polyethylene (page 9, lines 24-25), 300 ppm of I-3114 (a primary antioxidant that is an isocyanurate), 710 ppm of a I-168 (a secondary antioxidant that is a phosphite) (Example 1), and 380 ppm of zinc stearate (neutralizer) (Example 1). Graham et al. teach using a diphosphate interchangeably with a phosphite (Page 15, liens 3-9; Claim 1). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use a diphosphite in place of the phosphite in Example 1 of Graham et al. Graham et al. teach using hydrotalcite (layered double hydroxide) interchangeably with zinc stearate (Claim 1). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use a hydrotalcite in place of the zinc stearate in Example 1 of Graham et al. Graham et al. fail to teach HDPE with a bio-based carbon content. However, Nakanishi et al. teach using a bio-based HDPE, with 14C content so that even if it is incinerated, it does not increase the concentration of carbon dioxide in the atmosphere because of the carbon neutral property of the biomass [0020-0023, 0033, 0147]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the bio-based HDPE of Nakanishi et al. as the HDPE of Graham et al. so that even if it is incinerated, it does not increase the concentration of carbon dioxide in the atmosphere because of the carbon neutral property of the biomass. Regarding claims 4-5 and 7-8: Graham et al. teach the claimed primary antioxidant (Example 1), secondary antioxidant (page 15, lines 5-8), and hydrotalcite (claim 1), which comprises Mg and Al (page 16, lines 10-13). Regarding claims 9-12: Since the composition is the same as claimed, it will possess the claimed properties. The courts have stated that a chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. In re Spada, 911 F.2d 705, 15 USPQ2d 1655, (Fed. Cir. 1990). See also In re Best, 562 F.2d 1252, 195 USPQ 430, (CCPA 1977). "Where the claimed and prior art products are identical or substantially identical in structure or composition, or are produced by identical or substantially identical processes, a prima facie case of either anticipation or obviousness has been established." Further, if it is the applicant's position that this would not be the case, evidence would need to be provided to support the applicant's position. Claim(s) 3 and 6 is/are rejected under 35 U.S.C. 103 as being unpatentable over Graham et al. (WO 95/19391) and Nakanishi et al. (2022/0135778) as applied to claim 1 above further in view of Avakian et al. (EP 0781805 A1). Graham et al. teach adding a hindered amine stabilizer (claim 10). Graham et al. fail to teach the claimed compound. However, Avakian et al. teach that triisopropanol amine is a sterically hindered amine stabilizer known in the art, in an analogous composition (page 4, lines 5-7). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use triisopropanol amine as taught by Avakian et al. as the hindered amine stabilizer in Graham et al. to stabilize the composition. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-13 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-14 of copending Application No. 18/946307. Although the claims at issue are not identical, they are not patentably distinct from each other. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN USELDING whose telephone number is (571)270-5463. The examiner can normally be reached on M-F 8am to 6:30pm. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on 571-272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOHN E USELDING/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

May 11, 2023
Application Filed
Jun 11, 2026
Non-Final Rejection mailed — §103, §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679951
Resin Molded Body and Resin Molded Body Production Method
4y 1m to grant Granted Jul 14, 2026
Patent 12674043
Amino Silicone Polymer, Silicone Emulsion Comprising Same, and Method for Manufacturing Same
4y 6m to grant Granted Jul 07, 2026
Patent 12668683
HIGH-HEAT AND HIGH-SHEAR-RESISTANT HIGH-FLAME-RETARDANT HALOGEN-FREE FLAME-RETARDANT COMPOUND SYSTEM AND USE
3y 2m to grant Granted Jun 30, 2026
Patent 12649852
Hydrolysis-Resistant Polycarbonate Composition
3y 3m to grant Granted Jun 09, 2026
Patent 12643996
PROCESS FOR PRODUCING A POLYETHYLENE COMPOSITION COMPRISING BIMODAL OR MULTIMODAL POLYETHYLENE
3y 0m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
53%
Grant Probability
71%
With Interview (+17.7%)
2y 8m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1280 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month